Avoro Capital Advisors LLC Taysha Gene Therapies, Inc. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 21,700,000 shares of TSHA stock, worth $63.1 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
21,700,000
Previous 19,999,999
8.5%
Holding current value
$63.1 Million
Previous $27.8 Million
80.32%
% of portfolio
0.91%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding TSHA
# of Institutions
154Shares Held
244MCall Options Held
107KPut Options Held
17K-
Rtw Investments, LP New York, NY25MShares$72.8 Million0.89% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$68.5 Million1.19% of portfolio
-
Morgan Stanley New York, NY16.9MShares$49.1 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY12.6MShares$36.6 Million11.04% of portfolio
-
Goldman Sachs Group Inc New York, NY12.6MShares$36.6 Million0.0% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $141M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...